Mario Nicolini
Rimini, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Final results of the real-life observational VICTOR-6 study on metronomic chemotherapy in elderly metastatic breast cancer (MBC) patients.
Journal: Scientific reports
Published: April 06, 2023
Prognostic Value of Body Mass Index in Stage II/III Colon Cancer: Posthoc Analysis From the TOSCA Trial.
Journal: Clinical colorectal cancer
Published: July 13, 2022
Metronomic chemotherapy (mCHT) in metastatic triple-negative breast cancer (TNBC) patients: results of the VICTOR-6 study.
Journal: Breast cancer research and treatment
Published: August 13, 2021
Author Correction: Sex-Related Differences in Impact on Safety of Pharmacogenetic Profile for Colon Cancer Patients Treated with FOLFOX-4 or XELOX Adjuvant Chemotherapy.
Journal: Scientific reports
Published: February 02, 2020
Metronomic chemotherapy for advanced breast cancer patients in the real world practice: Final results of the VICTOR-6 study.
Journal: Breast (Edinburgh, Scotland)
Published: March 05, 2019
Sex-Related Differences in Impact on Safety of Pharmacogenetic Profile for Colon Cancer Patients Treated with FOLFOX-4 or XELOX Adjuvant Chemotherapy.
Journal: Scientific reports
Published: January 25, 2019
Phase II Study of Dehydroepiandrosterone in Androgen Receptor-Positive Metastatic Breast Cancer.
Journal: The oncologist
Published: August 27, 2018
Impact of Metformin Use and Diabetic Status During Adjuvant Fluoropyrimidine-Oxaliplatin Chemotherapy on the Outcome of Patients with Resected Colon Cancer: A TOSCA Study Subanalysis.
Journal: The oncologist
Published: July 23, 2018
Metronomic Chemotherapy in Triple-Negative Metastatic Breast Cancer: The Future Is Now?
Journal: International journal of breast cancer
Published: June 12, 2017
Dihydropyrimidine dehydrogenase pharmacogenetics for predicting fluoropyrimidine-related toxicity in the randomised, phase III adjuvant TOSCA trial in high-risk colon cancer patients.
Journal: British journal of cancer
Published: March 20, 2017
Metronomic chemotherapy with oral vinorelbine (mVNR) and capecitabine (mCAPE) in advanced HER2-negative breast cancer patients: is it a way to optimize disease control? Final results of the VICTOR-2 study.
Journal: Breast cancer research and treatment
Published: September 29, 2016
Development and pilot-testing of a new tool to screen psoriasis patients for the presence of psoriatic arthritis: the Simple Psoriatic Arthritis Screening (SiPAS) questionnaire.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: August 10, 2016
Last Updated: 09/26/2026